Ledger.Open graph →

SEC Form D · filed February 25, 2022

Kernal Biologics, Inc

Offering

$25.5M

Sold

$20.1M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

CAMBRIDGE, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Yusuf Erkul · Cambridge, MAExec · Director Burak Yilmaz · Cambridge, MAExec · Director Clark Holmes · New York, NYExec · Director Mohit Kaushal · Minneapolis, MNExec · Director Matthew Olivo · Rye, NYExec · Director F. M. Petronzio · CHICAGO, ILExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗